by Raynovich Rod | Jul 30, 2015 | Biopharmaceuticals
Update-1 Stealth End of Month Rally Stops Biotech Slide IBB up 3.4% In July and up 1% on Last Day Stocks roared out of the box on Friday but could not hold and ended flat. NASDAQ Up 2.3% for July. Most biotech stocks were green and momentum players came back in to...
by Raynovich Rod | Jul 16, 2015 | Biopharmaceuticals
Biotech Stocks More Subdued- as of Mid-Day 7/20 Trading Biotechnology stocks are taking a rest today after a torrid five days that saw the XBI up 7.31%, FBT up 6.19% and the IBB up 6.65%. Moreover on Friday 7/17 the trading in six or more biotech small caps made the...
by Raynovich Rod | Jul 14, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
Rayno Top Winners YTD 10/12/15 Fibrocell Science (FCSC) up 69% Clovis Oncology (CLVS) up 61.6% Regeneron (REGN) up 28.4% Seattle Genetics (SGEN) up 21.3% Gilead Sciences (GILD) up 5.6% —— Rayno Top Losers YTD Biogen Idec (BIIB) down 21.5%….down again...
by Raynovich Rod | Jul 8, 2015 | Biopharmaceuticals, Macro
7/13/15 12N EDT Roller Coaster Market MACRO to sidelines A wave of optimism reverses concerns about China and Greece. China stocks have recovered because there is still growth potential. Although a Greek deal is not finalized the glass is half full again and a Grexit...
by Raynovich Rod | Jun 30, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
Dealmaking and Fast Money Fuel Biotechs Q2 2015 Review Despite a major down trend at the end of April and the recent sell-off, the sector outperformed in Q2 of 2015. The S&P was down 1% and flat YTD. The XBI Biotech ETF continues to be the sector ETF leader up...
by Raynovich Rod | Jun 29, 2015 | Biopharmaceuticals
Biotech Stocks in Broad Sell-Off The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%. The sector, as tracked...
by Raynovich Rod | Jun 24, 2015 | BIOgraph, Biopharmaceuticals, Clinical Diagnostics and Tools
Updated 6/25 Precision Medicine -Novel Prevention and Treatment Strategies Lead The Way A New Initiative on Precision Medicine — NEJM Over 15,000 attended BIO 2015 in Philadelphia including 1100 companies and more than 30 nations. The Exhibits and Partnering meetings...
by Raynovich Rod | Jun 11, 2015 | 2024 Rayno Tools and Diagnostics Portfolio, Clinical Diagnostics and Tools
New technologies in diagnostics and tools are driving growth: NexGen sequencing, molecular and “point-of-care” testing platforms and veterinary testing. M&A and consolidation should continue. The sector is a laggard due to slowing sales and earnings...
by Raynovich Rod | Jun 9, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well. Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc Rapid Fire Re-Balancing of ETFs into More Speculative Names Is the Tail Wagging...
by Raynovich Rod | Jun 7, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
ASCO Week in Review- Rayno Biopharmaceutical Stocks The market action over the past week focused on speculative stocks rather than the overall biopharmaceutical sector. Major ETFs over five days were mixed with the smaller cap XBI up over 1%, the IBB flat and the FBT...
